Bharat Biotech vaccine may cost less than Serum s; govt working on pricing Ahead of the massive inoculation drive starting next week, the government is engaged with the vaccine makers to discuss their final pricing, according to people in the know. They indicated that Hyderabad-based player Bharat Biotech could price its indigenous candidate Covaxin lower than Covishield the AstraZeneca-Oxford vaccine manufactured by Serum Institute of India. The final contract is expected to be signed soon. Pricing took time as the government tried to get the best deal possible for the initial roll out.
Govt to hold spectrum auctions from March 1; DoT invites applications
Financial stability report delayed as govt wants to consult RBI The Financial Stability Report (FSR), which was scheduled to be released on Wednesday, has been delayed as the government wants to “consult” the Reserve Bank of India on the stance of the report. The new date for the release of the report has been tentatively fixed on January 11 next year. The discussion will be over the FSR’s stance on the future trend in non-performing assets (NPAs) and that of the government’s, which sources said, is relatively benign.
New margin norms: F&O turnover at record high in December, shows data
RBI may red-flag Punjab and Sind Bank s Rs 5,500-crore zero-coupon bonds The Reserve Bank of India (RBI) may red-flag the Rs 5,500-crore zero-coupon bonds issued towards recapitalising (recap) Punjab and Sind Bank (P&SB) in its current form, and ask it to hold the instrument in the held-to-maturity (HTM) portfolio at a discount and not at face value. “This (structure) has to be reworked. It is bad accounting, and has implications for the broader debt market.
After a stupendous rally in market, returns may moderate in 2021: Experts After a stupendous rally in the market from March lows, experts say returns may moderate in the new year. The market s trajectory in the calendar year 2021 (CY21), they believe, will be guided more by developments surrounding Covid-19 and its vaccine, oil prices, global central bank policies, and the US dollar s movement at the global level.
Economy well placed to capitalise on recovery in 2021, says K V Kamath With better-than-expected performance by Corporate India in the second quarter, the economy is better placed to capitalise on recovery in 2021, said veteran banker and chairman of the Reserve Bank of India’s (RBI’) debt restructuring panel K V KAMATH. In an interview with Abhijit Lele, he said India needs to be mindful of the pain that exists in the self-employed category and those with unsecured loans.
Faltering health infra gets a shot in the arm as vaccine roll-out nears If the year of the coronavirus pandemic stretched India’s health infrastructure to the limit, the sector seems to be much more battle ready for the challenges of 2021. The fight against Covid-19 has expanded now from treatment to prevention with the country preparing to roll out the massive and unique exercise of adult vaccinations. Government officials say that by next year, India could have a bouquet of half a dozen vaccines t
shannon: the results are in from shocking probe of b.p. oil spill. they are reporting that every defense signal failed last system. some were deployed and didn t work and others weren t deployed at all. 11 rig workers were killed in what is the largest environmental disaster in u.s. history. brenda buttner has look at the top business headlines of 2011. your money grabbing headline in 2010. starting off with a sweet deal. kraft food taking over cadbury for $19 million. merger in the sky is united and continental combining to form the largest airline. southwest airline scooping up airtran for $1 billion. goldman sachs agreeing to massive settlement with the